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Abstract 
Background: Human papillomaviruses (HPVs) are the most common viruses which can be sexually transmitted. 
They can cause different malignancies in asymptomatic women. The association of HPVs with infertility among men 
and women is controversial. In the current study, the authors compared the frequency of HPVs in fertile and infertile 
women in the city of Mashhad.  
Materials and Methods: In the present case-control study, cervical and vaginal smears were collected from 
infertile and fertile women. HPVs were detected by polymerase chain reaction. Data was analyzed by SPSS v.20 and 
P-value <0.05 was considered statistically significant.  
Results: In the current study, 115 infertile women with the mean age of 30.5±5.6 years and 60 fertile women with 
the mean age of 32.6±9.3 years were included (p=0.07). Among women who were infertile (cases), 121 (52.6%) of 
230 smears were positive, while in control group (who were fertile), 50 (41.7%) of 120 smears were positive 
(p=0.052).  
Conclusion: Frequency of HPV in both groups was high, which could be due to lack of routine HPV vaccination. 
HPV can cause placenta abnormality, our infertile women had multiple abortion history and history of abortion had 
significant differences among infertile and control group. The frequency of HPV had no significant differences 
between the infertile and control groups. 
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Failure to become pregnant after one year of 
regular unprotected sexual intercourse is defined as 
infertility. Infertility is one of the most common 
problems among young couples. It is estimated that 
in industrialized nations, 15% of people are infertile 
(1). Therefore, it has become a top priority for many 
health organizations and governments to tackle this 
issue. The reasons responsible for infertility are 
categorized in three different groups: genetic, 
anatomic and environmental factors. Infection is one 
of the environmental reasons which can cause 
infertility among men and women. Few studies 
suggested HPV as one of the causes of infertility in 
women (2). 
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Human papillomaviruses (HPVs) are non-
enveloped viruses with circular double stranded 
DNA (3, 4). They are the most common viruses 
which can be sexually transmitted. They can be 
transmitted through skin contact or any other surface 
contact related to the genital area. HPVs are 
distributed in the skin and mucous membranes, 
including the pubic area, oral cavity and perianal 
region. The lifetime risk of being infected with HPVs 
is 80% for any woman in the world (2). The age at 
which people begin sexual activities, being an 
immune compromised patients and the number of 
sexual partners, are positively related with this 
infection. About 100 different HPV types are known 
that are able to cause a variety of complications 
including malignancy due to the infection of basal 
keratinocytes of the epidermis (5, 6). The most 
common types which cause cervical cancers are 
types 16 and 18 (7-11). Screening test is 
recommended for all sexually active women, since 
most of the infected women with type 16 and 18 have 
no symptoms until they develop malignancies. 
Polymerase chain reaction test is one of the accurate 
ways for detecting HPVs (12). The aim of the current 
study was to compare the frequency of HPVs in 
infertile and fertile women, effects of marriage 
duration and HPV frequency, compare HPV 
frequency in cervical and vaginal specimens and 
relation between history of abortion and infertility in 
Mashhad, northeast of Iran. 
Methods 
The current case control study was performed 
from 2012 to 2015. Approval was received from the 
Research Ethics Committee of Mashhad University 
of Medical Sciences. The current study was 
supported by Mashhad University of Medical 
Sciences, Mashhad, Iran. (Grant No. 900506). 
Informed written consent was obtained from 115 
infertile women who were admitted to the center for 
reproduction at Montaserieh hospital in Mashhad and 
60 fertile women as a control group. All participants 
had no history of smoking, addiction, high risk 
sexual behavior and other medical complications 
such as autoimmune diseases. All participants had 
one sexual partner. Cervical and vaginal smears were 
taken by gynecologists.  
DNA was extracted using extraction buffer 
consisted of Tris-Cl (100 mM, pH 7.5) and Tween-20 
(0.05%) as described previously (13). Prepared 
samples were used directly for polymerase chain 
reaction (PCR) amplification without more 
purification steps. To assess the quality of extracted 
DNA, PCR of β-globin gene was performed. 
In the current study, the quality of the extracted 
DNA was determined by amplification of a 260-bp 
fragment of the β-globin gene. PC04 and GH20 
primers were used for PCR amplification. PCR 
reaction mixture contained 1 µL (100 ng) of DNA, 0.8 
µL of Taq DNA polymerase (5 U/µL, CinnaGen, 
Iran), 0.4 µL of dNTPs (10 mM), 1.6 µL of MgCl2 (25 
mM), 2.5 µL of 10X PCR buffer, and 10 pmol/µL of 
each primer, in a total reaction volume of 25 µL. PCR 
amplification was performed for 35 cycles (94 °C for 
30 s, 55 °C for 30 s, and 72 °C for 45 s) after an initial 
denaturation step of 94 °C for 5 min. The cycles were 
followed by a 7-min extension at 72 °C. PCR product 
was visualized on a 2% agarose gel by green viewer 
(Pars Tous, Iran) staining and UV photography. 
In order to determine the presence of HPVs in 
the extracted DNA samples, GP5+ (5´-
TTTGTTACTGTGGTAGATACTAC-3´) and GP6+ 
(5´-GAAAAATAAACTGTAAATCATATTC-3´) 
primers were used to amplify a 142-bp fragment of L1 
which was a highly conserved sequence of HPV 
genome. By performing this PCR, almost all HPV 
types, including high and low risk types, could have 
been identified. PCR reaction mixture consisted of 1 
µL of DNA (100 ng/µL), 0.3 µL of Taq DNA 
polymerase (5 U/µL, CinnaGen, Iran), 0.4 µL of dNTP 
(10 mmol), 0.6 µL of MgCl2 (50 mmol), and 10 
pmol/µL of each primer, in a total volume of 25 µL. 
PCR program was as follows: denaturation for 5 min 
at 94 °C; 35 cycles of 94 °C for 45 s, 47.5 °C for 45 s, 
and 72 °C for 45 s; and a final extension of 72 °C for 7 
min. Fragment sizes of PCR products were assessed 
by comparison with a 100 bp DNA size marker in a 
2% agarose gel. 
 Data was analyzed by SPSS v.18 (Chicago, IL, 
USA) software and Chi-Square test, Mann-Whitney U 
test, Fisher's Exact Test were used. For control 
confounding variables, Logistic regression was applied 
to compare between the duration of marriage (years), 
the history of abortion, and the HPV infection with the 
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All samples showed a band corresponding to 
260-bp in the PCR of β-globin gene. Samples were 
amplified for a fragment of a highly conserved region 
of L1 gene of HPV (HPV L1). Among the infertile 
women, 121 (52.6%) of 230 smears were positive, 
while 50 (41.7%) of 120 smears were positive in the 
control group (p=0.052) (Figure 1). 
Age distribution in infertile and fertile women 
is shown in figure 2. The mean of age of infertile 
women was 30.5±5.6 years and the mean of age of 
fertile women was 32.6±9.3 years (p=0.07). HPV 
infection was detected in infertile and fertile women 
by PCR method and the differences was not 
statistically significant (P-Value =0.052). 
The presence of HPV infection (evaluated by 
PCR) among the infertile and fertile women 
according to their age is shown in Table 1. 
The history of previous abortion was found in 
15 (60%) and 19 (26.4%) of infertile and fertile 
women, respectively. The differences between 
infertile and fertile groups in history of previous 
abortion was statistically significant (p=0.002). The 
number of abortions in infertile and fertile women was 
analyzed based on the number of abortions and it was 
shown to be statistically significant (P-Value=0.0001) 
(Table 2). The status of HPV infection was evaluated 
among the infertile and fertile women based on their 
previous abortions and the differences was not 
statistically significant.  
 The mean of the duration of marriage in 
infertile group was 6.1±3.4 years while in control 
group, it was 9.6±7.2 years. The status of HPV 
infection (evaluated by PCR) in infertile and fertile 
women according to the duration of marriage was 
evaluated and the difference was not statistically 
significant. The distribution of the duration of 
infertility in the infertile group is shown in figure 3. 
Vaginal and cervical specimens were used in 
our study and the DNA extraction was performed by 
the same method in both specimens. HPV infection 
was detected in the extracted DNA by PCR. The status 
 
Figure 1. Agarose gel electrophoresis of β-globin and HPV L1 PCR 
products.  PCR was used for amplification of a 260bp fragment of β-
globin and a 142bp fragment of HPV L1 fragments. Lanes 3, 4, and 5 
represent β-globin and HPV L1 positive samples. Lanes 7 and 8 are 
negative and positive controls for the PCR amplification, respectively. 
Lanes 1 and 2 showed HPV L1 negative samples. Lane 6 represents the 
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Figure 2. Age distribution in infertile and fertile women 
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of HPV infection based on type of specimens were 
evaluated and it was shown to be statistically 
different in infertile and fertile women (P-
Value=0.024) (Table 3). 
No association was found between the 
duration of marriage and the positive HPV test 
(p=0.08).  
Logistic regression analysis between the 
duration of marriage (years), the history of abortion, 
and HPV infection with a chance of infertility 
showed history of abortion increased chance of 
infertility by about 3.68 times that is statistically 
significant while positive HPV infection that increases 
the chance of infertility by 1.43%, is not statistically 
significant (Table 4). 
Discussion 
HPV is one of the most common sexually 
transmitted diseases that affects between 100 and 200 
new cases per 100,000 adults in the general population 
in the world per year (14, 15). A recent study on 825 
married women aged 18-59 years from the general 
population of Tehran (Iran) showed that the 
prevalence of HPV was 7.8%, with no significant 
Table 1: Distribution of HPV infection (evaluated by PCR) among the infertile and fertile women according to their age  
Statistic Test 
P-Value 
Total (n (%)) HPV infection 
Negative (n (%)) 
HPV infection 











































# Pearson Chi-Square 
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* Statistically significant 
 
Table 2: The number of abortions among infertile and fertile women  
Statistic Test* 
P-Value 
Total (n (%)) Fertile (n (%)) Infertile (n (%)) No. of abortions 
 62 (63.9%) 53 (73.6%) 9 (36.0%) 0 
-3.62 
0.0001** 
24 (24.7%) 15 (20.8%) 9 (36.0%) 1 
8 (8.2%) 3 (4.2%) 5 (20.0%) 2 
 3 (3.1%) 1 (1.4%) 2 (8.0%) 3 
 97 (100%) 72 (100%) 25 (100%) Total (n (%)) 
* Mann-Whitney U 
** Statistically significant 
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variation by age (16). In the present study, the 
prevalence of HPV was 48.6%. These differences 
may have been due to the geographical differences or 
the relatively lower number of participants in the 
current study. HPV positivity is more common 
among young males and females, due to have a 
higher tendency to find new partners at the peak age 
of new partner acquisition (17).  
In the present study, 52.6% of infertile women 
were positive for HPVs. However, in Lundqvist et al 
study, 7% of them were positive (18). This difference 
may have been due to vaccination to protect young 
women against HPV types 6, 11, 16 and 18 (19). 
Health authorities in Iran are strongly recommended 
to provide nation-wide vaccination against HPV 
among young girls. In Spandorfer et al study in New 
York (USA), HPV was detected in 17 (16.0%) of 106 
infertile patients. They showed that HPV-positive 
women had a decreased pregnancy rate (4 of 17, 
23.5%) as compared with HPV-negative women (51 
of 89, 57.0%; P<.02) (20). In Coso’s study, 75% of 
HPV infected infertile women became fertile after 
receiving treatment for HPV (21). In a recent study 
by Perino et al, it was showed that HPV infected 
couples had an increased risk of pregnancy loss after 
assisted reproduction technique compared with non-
infected couples (22). 
The role of HPV in causing infertility in 
women and men is controversial. In some studies, it 
was showed that HPV caused infertility in men by 
changing the motility and morphology of sperms (23, 
24). However, Schillaci and colleagues found that 
only 24 of 308 semen samples (7.8%) were HPV 
DNA positive in infertile men (25). HPV cervical 
infection has risk factors for tub peritoneal sterility, 
and patients are also in risk of other sexually 
transmitted diseases. In the current study, similar to 
that of Lundqvist’s study (in which the frequency of 
HPV in infertile and fertile women were 7.0% and 
9.1%, respectively), there was no significant 
differences between the frequency of HPV in infertile 
and fertile groups (18).  Also, Strehler and colleagues 
found no statistically significant differences in the 
prevalence of HPV DNA between infertile women and 
healthy control women (26). In other studies in 
different countries, HPV had a higher prevalence rate 
among infertile group compared to that of control 
group (20, 27, 28). 
In Ambuhl study, they found significant 
difference between HPV prevalence and spontaneous 
abortion (29). According to some studies HPV 
considered as one of the reason of abortion by causing 
abnormal implantation and placental dysfunction in 
pregnant women (30, 31). In this study, there was 
significant difference between history of abortion and 
infertility. Our infertile women had multiple abortion 
history. To our knowledge, in the worldwide, there 
was no previous study regarding the association of the 
duration of marriage in HPV affected patients. The 
authors found no relationship between the duration of 
marriage with being infected with HPV. 
Conclusion 
In conclusion, in the current study, the 
frequency of HPV had no statistically significant 
association among infertile and fertile women. 
However, the prevalence of HPV in both groups of 
participants was high. Thus, it is not possible to 
exclude the possible adverse effects of HPV infection 
on infertility. In other words, its early detection may 
lower the frequency of cervical cancer and infertility. 
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Table 4: Logistic regression between the duration 
of marriage (years), the history of abortion, and the 
HPV infection with the chance of infertility 
Exp(B) Sig. Variable(s) entered on step 1 
1.019 0.583 Duration of marriage 
3.681 0.001** History of abortion 
1.430 0.353 HPV positive results 
* Logistic regression 
** Statistically significant 
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